N/A
Manufactured by CVS Pharmacy
7,282 FDA adverse event reports analyzed
Last updated: 2026-04-15
BACITRACIN is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by CVS Pharmacy. The most commonly reported adverse reactions for BACITRACIN include DRUG HYPERSENSITIVITY, DRUG INEFFECTIVE, PAIN, NAUSEA, DIARRHOEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for BACITRACIN.
Out of 3,692 classified reports for BACITRACIN:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 7,282 FDA FAERS reports that mention BACITRACIN. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DRUG HYPERSENSITIVITY, DRUG INEFFECTIVE, PAIN, NAUSEA, DIARRHOEA, DYSPNOEA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list CVS Pharmacy in connection with BACITRACIN. Always verify the specific product and NDC with your pharmacist.